SPRINGWORKS THERAPEUTICS, INC. (SWTX) Social Stream



SPRINGWORKS THERAPEUTICS, INC. (SWTX): $27.61

0.85 (+3.18%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add SWTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#250 of 381

in industry

SPRINGWORKS THERAPEUTICS INC (SWTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SWTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 4 $137 $92 $111.5 $27.69 302.67%
2022-02-24 4 $137 $105 $114.75 $27.69 314.41%
2022-02-25 4 $137 $101 $113.25 $27.69 308.99%
2022-05-09 5 $142 $101 $114.5 $27.69 313.51%
2022-05-11 5 $142 $98 $113.75 $27.69 310.8%
2022-05-27 6 $142 $50 $98.75 $27.69 256.63%
2022-06-06 6 $105 $50 $87 $27.69 214.19%
2022-06-12 6 $105 $53 $87.75 $27.69 216.9%
2022-08-04 6 $105 $53 $86.6 $27.69 212.75%
2022-08-09 6 $105 $53 $86.4 $27.69 212.03%
2022-08-23 6 $105 $53 $84 $27.69 203.36%
2022-09-30 6 $105 $53 $85.8 $27.69 209.86%
2022-10-21 6 $105 $44 $78.2 $27.69 182.41%
2022-11-04 6 $105 $44 $77.2 $27.69 178.8%
2022-11-08 6 $105 $44 $70.6 $27.69 154.97%
2022-11-22 6 $105 $44 $69.2 $27.69 149.91%
2022-12-01 7 $105 $44 $65.166 $27.69 135.34%
2023-01-26 7 $105 $45 $65.333 $27.69 135.94%
2023-03-01 6 $105 $45 $65.333 $27.69 135.94%
2023-03-07 6 $105 $45 $66.333 $27.69 139.56%
2023-04-20 7 $105 $45 $67 $27.69 141.96%
2023-05-30 7 $105 $41 $56.333 $27.69 103.44%

The Trend in the Analyst Price Target


Over the past 22 months, SWTX's average price target has gone down $60.92.

SWTX reports an average of 171.95% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-04 6 105 53 86.600 34.39 151.82%
2022-08-09 6 105 53 86.400 36.00 140%
2022-11-04 6 105 44 77.200 23.90 223.01%
2023-04-20 6 105 45 67.000 23.68 182.94%
2023-05-05 7 105 41 56.333 23.60 138.7%

SWTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 120 days, SWTX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SWTX as an investment opportunity.

  • In terms of how SPRINGWORKS THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2025.16% of that group.
  • To contextualize these metrics, consider that out of all US stocks, SPRINGWORKS THERAPEUTICS INC's variance in analysts' estimates is lower than -1567.19% of them.
  • In the context of Pharmaceutical Products stocks, SPRINGWORKS THERAPEUTICS INC's average analyst price target is higher than 1965.49% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, SPRINGWORKS THERAPEUTICS INC's number of analysts covering the stock is higher than 779.14% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SPRINGWORKS THERAPEUTICS INC are ALLO, MESO, and ALVR.

Is SWTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7661 seconds.